Cost Effectiveness and Resource Allocation

Papers
(The TQCC of Cost Effectiveness and Resource Allocation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong36
The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review26
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency25
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea24
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”24
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening23
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China21
Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs21
Economic aspects of prolonged home video-EEG monitoring: a simulation study19
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial18
Tracking malaria health disbursements by source in Zambia, 2009–2018: an economic modelling study18
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model17
The economic burden of bipolar disorder: a case study in Southern Iran16
The appearance and increase in the quantity and proportion of the clinical research coordinator’s service fee in drug clinical trial research fund and its impact on trial quality16
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia15
A review on the evolving environment of medical device real-world evidence regulation on market access in the USA15
Real-world effectiveness of a new powered stapling system with gripping surface technology on the intraoperative clinical and economic outcomes of gastrectomy for gastric cancer15
Implementation of a vascular access specialist team in a tertiary hospital: a cost-benefit analysis14
The cost-effectiveness analysis of newborn screening for inherited metabolic disorders in China using tandem mass spectrometry: a real-world evidence14
Cost-effectiveness analysis of COVID-19 tests in the unified health system14
The role of routine chest radiography after implantable venous access port catheter insertion under the guide of ultrasonography and fluoroscopy13
Comparative Efficiency Analysis of OECD Health Systems: FDH vs. Machine Learning Approaches with Efficiency Analysis Trees (EAT and RFEAT)13
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran12
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study12
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer11
Evaluation of an Alternative Learning System for youths at risk of involvement in urban violence in the Philippines11
Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan11
Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis—with an illustrative case of HIV treatment in Moz10
Heterogeneity in health funding and disparities in health outcome: a comparison between high focus and non-high focus states in India10
Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review10
Health system productivity in sub-Saharan Africa: tuberculosis control in high burden countries10
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?10
What alternative and innovative domestic methods of healthcare financing can be explored to fix the current claims reimbursement challenges by the National Health Insurance Scheme of Ghana? Perspectiv10
Temporal trend of comorbidity and increasing impacts on mortality, length of stay, and hospital costs of first stroke in Tianjin, North of China9
A qualitative study on patient-centered care and perceptions of nurses regarding primary healthcare facilities in Nigeria9
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model9
Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran8
Economic burden of knee joint replacement in Iran8
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?8
Title: the impact of a pilot integrated care model on the quality and costs of inpatient care among chinese elderly: a difference-in-difference analysis of repeated cross-sectional data8
Cost-effectiveness of high-dose vitamin D supplementation to reduce the occurrence of repeat episodes of pneumonia in children8
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis8
Contextualization of cost-effectiveness evidence from literature for 382 health interventions for the Ethiopian essential health services package revision8
The application of artificial intelligence in health financing: a scoping review8
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value8
Associations between treatment burden, self-reported treatment qualities, antiretroviral therapy obtainment, and health-related quality of life among Ugandan PLWH8
An assessment of adherence to the WHO-delineated good manufacturing practice by the pharmaceutical companies in Kabul, Afghanistan7
Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure7
The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study7
The impact of government subsidy programs on equity in health financing7
Financial burden of prostate cancer in the Iranian population: a cost of illness and financial risk protection analysis7
Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained setting7
Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis7
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness7
Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey7
Correction: One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis7
Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial7
Measuring efficiency of public hospitals under the impact of Covid-19: the case of Türkiye7
Tuberculosis prevention, diagnosis, and treatment financial profile during 2006–2021: PART A7
Loss ratio of the capitation payment unit of the health-promoting entities in Colombia between 2017 and 2021: a financial–actuarial approach7
Valuating the efficiency of social security and healthcare in OECD countries from a sustainable development7
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis6
Population ageing and sustainability of healthcare financing in China6
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique6
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients6
Powered stapling system with gripping surface technology for pulmonary resection of lung cancer: real-world clinical effectiveness6
Global bibliometric analysis of cost effectiveness analysis in healthcare research from 2013 to 20236
Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review6
What are the short-term annual cost savings associated with kidney transplantation?6
Cost-utility analysis of TAVI compared with surgery in patients with severe aortic stenosis at low risk of surgical mortality in the Netherlands6
Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China6
One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis6
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis6
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial6
Understanding the impact of unequal utilization of medical services on the consumption of resources in hemophilia6
The impact of media reports on energy and environmental efficiency in China: evidence from modified dynamic DEA with undesirable outputs5
Strategies for reducing out of pocket payments in the health system: a scoping review5
Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China5
Methodological challenges surrounding QALY estimation for paediatric economic evaluation5
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective5
How a thrombectomy service can reduce hospital deficit: a cost-effectiveness study5
Association between ethnicity and health knowledge among the floating population in China5
Indirect comparison between powered and manual circular staplers for left-sided colorectal anastomoses: clinical and economic outcomes in China5
Excess healthcare costs of mental disorders in children, adolescents and young adults in the Basque population registry adjusted for socioeconomic status and sex5
The effect of Covid-19 pandemic on the primary health care utilization and cost: an interrupted time series analysis5
Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China5
Correction: Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis5
Comparing swab- and different symptoms-based strategies to ascertain COVID-19 recovery in healthcare workers: a cost-effectiveness analysis5
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis5
Operative vs. conservative treatment of AC-Joint Dislocations Rockwood grade ≥ III -An economical and clinical evaluation-5
Systematic review of economic evaluations for paediatric pulmonary diseases5
Cost and efficiency analysis in Iranian primary health centers: a micro costing and data envelopment analysis5
0.067085027694702